1300 111 ASN (276)

Thermonuke Pink Ops 2nd Strike

Recon

$79.95

Free Shipping with every purchase of Thermonuke Pink Ops 2nd strike

Thermonuke Pink Ops 2nd Strike

Wishlist

RECON THERMONUKE PINK OPS 2nd strike : REDESIGNED THERMOGENIC FOR FEMALES.

Recon’s best selling Thermonuke Thermogenic fat loss metaboliser has been re-engineered to cater specifically for women wanting to get more out of their weight loss efforts, or maintain a lean physique all year round.

Designed around Thermonuke’s potent combination of stimulating compounds and fat metabolisers Recon Thermonuke Pink Ops 2nd Strike contains additional DIM and Calcium D Glucarate, which act as effective fat burning ingredients on their own, amplifier the power of Thermonuke’s formula to create a powerful thermogenic, unmatched by competition.

With a formula specifically designed to support estrogen balance and increase healthy cell replication, Recon Thermonuke Pink Ops 2nd Strike caters one of the most reputable thermogenics on the market for female athletes, to get more out of your training than ever before. Available in delicious Pineapple Splice, Wild Peach and Apple, take Thermonuke Pink Ops 2nd Strike before your workout and prepare for unprecedented results.

 

Begin using One (1) level scoop in 200ml of cold water 30 minutes prior to training. Special Ops dosing protocol is two (2) scoops for elite users.

Ingredients

Pouchong Tea Extract, Raspberry Ketones, Caffeine Malate, Uva Ursi (leaf), Dandelion Root Extrat (root), Caffeine Citrate, Niacin, Nandino Domestica, Dim, Calcium D Glutarate.

Serving Size: One Scoop (2.6 grams)
Servings per container: 60  
 
Thermonuke Prop Blend   4515mg
Pouching Tea, Raspberry Ketones, Dandelion Root Powder, Infenergy Dicaffeine Malate, Caffeine Citrate, Niacin, Nandia Domestica (Higenamine), DIM, Calcium D Glutarate  

 

Other Ingredients: Maltodextrin, Citric Acid, Malic Acid, Natural And Artificial Flavouring, Sucralose, Beet Root Powder, Silica, Calcium Silicate, Acesulfame Potassium.

Sign up for the ASN newsletter